IMV

Leadership team

Mr. Andrew Hall M.Sc. (CEO & Director)

Dr. Jeremy R. Graff (Chief Scientific Officer)

Ms. Brittany Davison C.A., CPA (Corp. Sec. & Chief Accounting Officer)

Products/ Services

Biotechnology, Health Care

Number of Employees

50 - 100

Headquarters

Dartmouth, Nova Scotia, Canada

Established

2000

Company Registration

SEC CIK number: 0001734768

Traded as

IMV

Social Media

URL

https://www.imv-inc.com

Overview

Location

Recognition and Award

References

Summary

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

History

IMV Inc. was founded in 1997 and has since established itself as a leader in the medical imaging and data acquisition industry. With decades of experience, the company has developed and released a wide range of medical imaging technologies and image analysis solutions that have been used by medical professionals all over the world.

Mission

Our mission is to provide superior imaging and data acquisition solutions to healthcare professionals and to be at the forefront of developing and delivering life-saving technologies.

Vision

We aspire to be the most trusted and reliable name in medical imaging and data acquisition solutions, leveraging our experience and expertise to serve our customers in their mission to improve patient care.

Key Team

Delphine Davan (Sr. Director of Communications & Investor Relations)

Ms. Linda Barabe M.B.A. (Sr. VP of HR & Internal Communications)

Dr. Marianne Stanford (VP of R&D)

Dr. Heather Hirsch (VP of Translational Research)

Mr. Stephan Fiset (VP of Clinical Research)

Recognition and Awards

IMV Inc. has received numerous awards over the years, including the prestigious MIT Technology Review Top 50 Innovators Award in 2009 and a Medical Imaging Award from the American College of Radiology in 2018.